PERNIX THERAPEUTICS HLDGS IN's ticker is PTX and the CUSIP is 71426V108. A total of 59 filers reported holding PERNIX THERAPEUTICS HLDGS IN in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $99,000 | -58.4% | 94,167 | +16.7% | 0.00% | -100.0% |
| Q4 2015 | $238,000 | -4.8% | 80,706 | +1.9% | 0.00% | 0.0% |
| Q3 2015 | $250,000 | -46.9% | 79,220 | -0.4% | 0.00% | 0.0% |
| Q2 2015 | $471,000 | -27.4% | 79,520 | +31.0% | 0.00% | -50.0% |
| Q1 2015 | $649,000 | +12.1% | 60,689 | -1.6% | 0.00% | +100.0% |
| Q4 2014 | $579,000 | +22.7% | 61,689 | +0.4% | 0.00% | 0.0% |
| Q3 2014 | $472,000 | -13.6% | 61,427 | +1.1% | 0.00% | 0.0% |
| Q2 2014 | $546,000 | +223.1% | 60,778 | +92.5% | 0.00% | – |
| Q1 2014 | $169,000 | +111.2% | 31,578 | 0.0% | 0.00% | – |
| Q4 2013 | $80,000 | -7.0% | 31,578 | 0.0% | 0.00% | – |
| Q3 2013 | $86,000 | -21.8% | 31,578 | +3.4% | 0.00% | – |
| Q2 2013 | $110,000 | +26.4% | 30,528 | +74.4% | 0.00% | – |
| Q1 2013 | $87,000 | – | 17,506 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|